EAM
CRDF icon

Eventide Asset Management’s Cardiff Oncology CRDF Stock Holding History

Eventide Asset Management’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,467,922
Closed -$3.64M – 140
2022
Q1 		$3.64M Sell
1,467,922
-202,477
-12% -$716K 0.06% 128
2021
Q4 		$10M Hold
1,670,399
– – 0.13% 113
2021
Q3 		$11.1M Sell
1,670,399
-1,905,435
-53% -$12M 0.15% 121
2021
Q2 		$23.8M Buy
3,575,834
+1,792,346
+100% +$15.2M 0.32% 83
2021
Q1 		$16.5M Buy
+1,783,488
New +$21.7M 0.24% 98

Other funds holding CRDF

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LCM
Laurion Capital Management New York $1.07B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return